Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147516 | SCV000194953 | likely benign | not specified | 2013-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312975 | SCV000849192 | uncertain significance | Inborn genetic diseases | 2017-03-10 | criteria provided, single submitter | clinical testing | The c.-2C>T variant is located in the 5' untranslated region (5’ UTR) of the SLC2A1 gene. This variant results from a C to T substitution 2 bases upstream from the first translated codon. This nucleotide position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. |
Gene |
RCV001731395 | SCV001981903 | uncertain significance | not provided | 2024-09-05 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Alters the Kozak sequence, which plays a major role in the initiation of translation |
Revvity Omics, |
RCV001731395 | SCV003825657 | uncertain significance | not provided | 2022-10-12 | criteria provided, single submitter | clinical testing |